Long-term progression-free survival of hepatocellular carcinoma with synchronous diffuse peritoneal metastasis treated by CRS+HIPEC: A case report and literature review

RATIONALE: Hepatocellular carcinoma (HCC) with peritoneal metastasis (PM) is rare. There has been no standard treatment for this severe disease, and the conventional palliative therapy could only reach an overall survival of 6 to 14 months PATIENT CONCERNS: A 38-year-old male with a chief complain o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Zhong-He, An, Song-Lin, Li, Xin-Bao, Liu, Gang, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408117/
https://www.ncbi.nlm.nih.gov/pubmed/30813197
http://dx.doi.org/10.1097/MD.0000000000014628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408117/
https://www.ncbi.nlm.nih.gov/pubmed/30813197
http://dx.doi.org/10.1097/MD.0000000000014628

Ejemplares similares